Your session is about to expire
← Back to Search
Behavioral Intervention
Intervention for Breast Cancer (B-SINCERE Trial)
N/A
Waitlist Available
Led By Elissa Ozanne, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
B-SINCERE Trial Summary
This trial aims to see if providing additional help in navigating community services alongside the usual process of referring for social needs can help improve follow-up for abnormal breast cancer screening results. Researchers will test if this combined
Who is the study for?
This trial is for women who are underserved and have had abnormal breast cancer screening results. It's designed to see if extra help from community services can improve follow-up care compared to the usual referral process.Check my eligibility
What is being tested?
The study is testing whether adding a 'community services navigation' support helps women with abnormal breast cancer screenings better than the standard care they usually get, which might just be a simple referral.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like additional guidance and support rather than drugs or medical procedures, there aren't typical side effects as seen in drug trials.
B-SINCERE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in participants' level of social needs as measured by the B-SINCERE (Breast-Screener for Intensifying Community Referrals for Health) screener
Episode Completion (EC). EC is the name of a dichotomous scale, reported on a 2-point scale that is calculated from patient electronic health record (EHR), with 0=No Breast Cancer Screening completed, 1=Breast Cancer Screening completed.
B-SINCERE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention
Find a Location
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,951,129 Total Patients Enrolled
49 Trials studying Breast Cancer
109,335 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,932,217 Total Patients Enrolled
939 Trials studying Breast Cancer
1,541,910 Patients Enrolled for Breast Cancer
University of UtahLead Sponsor
1,098 Previous Clinical Trials
1,777,180 Total Patients Enrolled
14 Trials studying Breast Cancer
5,674 Patients Enrolled for Breast Cancer
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available vacancies for participants in this clinical trial?
"As per the details on clinicaltrials.gov, this particular research investigation is not presently accepting new participants. The trial became available for review on March 1st, 2024, with its latest update recorded on March 8th of the same year. Despite this trial being inactive in terms of recruitment currently, it's noteworthy that there are a total of 2667 other ongoing studies actively seeking patient involvement."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger